iifl-logo

SBI Healthcare Opportunities Fund G

SBI Healthcare Opportunities Fund G

Fund Name

SBI Mutual Fund

Scheme Name

SBI Healthcare Opportunities Fund G

AMC

SBI Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

04-Jun-1999

Fund Manager

Tanmaya Desai

Net Assets (Rs. cr)

3822.73

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

SBI Healthcare Opportunities Fund G - Nav Details

Nav Date

:  12-Feb-2026

NAV [Rs.]

:  -

Buy/Resale Price [Rs.]

-

Sell/Repurchase Price [Rs.]

-

Entry Load %

Exit Load %

SBI Healthcare Opportunities Fund G- NAV Chart

SBI Healthcare Opportunities Fund G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
1.33
-0.63
-3.03
-0.56
0.29
23.84
15.57
14.94
Category Avg
2.49
-0.72
-2.26
-0.7
5.33
23.01
15.04
13.12
Category Best
4.05
1.75
1.24
2.98
13.1
27.89
17.6
28.09
Category Worst
0.07
-5.03
-6.75
-5.08
-4.28
18.46
11.03
-5.93

SBI Healthcare Opportunities Fund G- Latest Dividends

No Records Found

SBI Healthcare Opportunities Fund G- Investment Details

Min. Investment(Rs.)

5000

Increm.Investment(Rs.)

1000

In & Out

In

InName Of The CompanyNo Of Shares
Apollo Hospitals3,00,000
Sai Life6,00,000

Out

InName Of The CompanyNo Of Shares
Cipla10,00,000

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology10.022400000382.87
EquityDivi's Lab.Pharmaceuticals & Biotechnology6.96440000266.24
EquityApollo HospitalsHealthcare Services5.46300000208.81
EquityMax HealthcareHealthcare Services5.012000000191.36
EquityLupinPharmaceuticals & Biotechnology4.73840000180.83
EquityAcutaas ChemicalPharmaceuticals & Biotechnology4.50900000172.12
EquityTorrent Pharma.Pharmaceuticals & Biotechnology4.14400000158.43
EquityAether Industri.Chemicals & Petrochemicals3.671400000140.28
EquityBioconPharmaceuticals & Biotechnology3.603750000137.55
EquityAster DM Health.Healthcare Services3.472400000132.51
EquityLaurus LabsPharmaceuticals & Biotechnology3.331320000127.38
Foreign EquityLonza GroupPharmaceuticals & Biotechnology3.25200000124.30
EquityJupiter Life LinHealthcare Services3.18900000121.60
EquityFortis Health.Healthcare Services3.121400000119.21
EquityMankind PharmaPharmaceuticals & Biotechnology3.00540000114.69
EquityAlkem LabPharmaceuticals & Biotechnology2.97200000113.55
EquityGland PharmaPharmaceuticals & Biotechnology2.90600000110.79
EquityPoly MedicureHealthcare Equipment & Supplies2.5564000097.33
EquityKrishna Institu.Healthcare Services2.53160000096.60
EquityAbbott IndiaPharmaceuticals & Biotechnology2.523500096.47
EquityConcord BiotechPharmaceuticals & Biotechnology2.2172000084.61
EquityAurobindo PharmaPharmaceuticals & Biotechnology2.2170000084.53
EquityAnthem BiosciencPharmaceuticals & Biotechnology2.19140000083.90
EquitySudeep PharmaPharmaceuticals & Biotechnology2.14134188781.74
EquitySai LifePharmaceuticals & Biotechnology1.3160000050.10
EquityCohance LifePharmaceuticals & Biotechnology1.20120000045.75
EquityPfizerPharmaceuticals & Biotechnology1.1910000045.63
EquityNephrocare HealtHealthcare Services1.1080000042.21
EquityMedplus HealthRetailing1.0550000039.94
EquityVijaya Diagnost.Healthcare Services1.0040000038.34
EquitySanofi ConsumerPharmaceuticals & Biotechnology0.837500031.85
EquityGufic BioSciencePharmaceuticals & Biotechnology0.80100000030.72
EquityCorona RemediesPharmaceuticals & Biotechnology0.3910000014.79

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
SBI Mutual Fund
Incorporation Date:
07-Feb-1992
Total Assets Managed (Cr.):
12,63,744.61
Trustee/s:
Sandra Martyres, Bharati Rao, Smt. Manju Agarwal, SBI Mutual Fund Trustee C, Richard Mendonca, Mr. Dhruv Prakash
Chairman:
NA
CEO / MD:
Nand Kishore
CIO:
NA
President:
NA
Director/s:
Om Prakash Gahrotra, Dr. Prafulla Agnihotri, Mrs. Madhu Dubhashi
Compliance Officer/s:
NA
Investor Service Officer/s:
NA
Fund Manager/s:
Tanmaya Desai
Auditors:
Sudit K Parekh & Co, M/S Chandabhoy&Jassoobhoy

OTHER INFORMATION

Registered Office:
9th Floor,Crescenzo, C-39&39, G Block, Bandra kurla complex, Bandra (east), Mumbai-400 051.
Contact Nos:
022-61793000
Fax:
022-67425687
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.